Answer
Cerdelga (eliglustat tartrate) is indicated for long-term treatment of adults with Gaucher disease type 1 who are CYP2D6 poor, intermediate or extensive metabolisers.
Sources for this answer
- Cerdelga 84 mg capsules, hardSANOFI · emc · SmPC §4.1 Therapeutic Indications · Version 13Document updated
Sources checked